A descriptor of amino acids SVWG and its applications in peptide QSAR

Journal of Chemometrics

Volumn 26, Issue 10, 2012, Pages 549-555

  Tong, Jianbo ^a   Chen, Yang ^a   Liu, Shuling ^a   Che, Ting ^a   Xu, Xiameng ^a  

^a SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Amino acids; Partial least squares; Peptide; Quantitative structure activity relationship; SVWG

Indexed keywords

BIOACTIVITY; COMPUTATIONAL CHEMISTRY; LEAST SQUARES APPROXIMATIONS; MOLECULAR GRAPHICS; PEPTIDES; PRINCIPAL COMPONENT ANALYSIS;

AMINO-ACIDS; CORRELATION COEFFICIENT; DESCRIPTORS; ITS APPLICATIONS; MOLECULAR INDEX; PARTIAL LEAST-SQUARES; PRINCIPAL COMPONENTS; PRINCIPAL-COMPONENT ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; SVWG;

AMINO ACIDS;

EID: 84867336563     PISSN: 08869383     EISSN: 1099128X     Source Type: Journal    
DOI: 10.1002/cem.2465     Document Type: Article

References (45)

1. Jirácek J, Yiotakis A, Vincent B, Lecoq A, Checler F, Dive V. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry. J. Biol. Chem. 1995; 270: 21701-21706.
2. Marraud M, Aubry A. Crystal structures of peptides and modified peptides. Biopolymers 1996; 40: 45-83.
3. Zaliani A, Gancia E. MS-WHIM scores for amino acids: a new 3D-description for peptide QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 1999; 39: 525-533.
4. Zhou X, Li ZC, Dai Z, Zou XY. QSAR modeling of peptide biological activity by coupling support vector machine with particle swarm optimization algorithm and genetic algorithm, J. Mol. Graph. Model. 2010; 10: 1016-1024.
5. Liu SS, Yin CS, Cai SX, Li ZL. A novel MHDV descriptor for dipeptide QSAR studies, J. Chin. Chem. Soc. 2001; 48: 253-260.
6. Raychaudhury C, Banerjee A, Bag P, Roy S. Topological shape and size of peptides: identification of potential allele specific helper T cell antigenic sites. J. Chem. Inf. Comput. Sci. 1999; 39: 248-254.
7. Sneath PH. Relations between chemical structure and biological activity in peptides. J. Theor. Biol. 1966; 12: 157-195.
8. Kidera A, Konishi Y, Oka M, Ooi T, Scheraga HA. A statistical analysis of the physical properties of the 20 naturally occurring amino acids. J. Protein Chem. 1985; 4: 23-55.
9. Hellberg S, Sjostrom M, Wold S. The prediction of bradykinin potentiating potency of pentapeptides. An example of a peptide quantitative structure-activity relationship. J. Acta. Chem. Scand. B. 1986; 40: 135-140.
10. Sandberg M, Eriksson L, Jonsson J, Sjöström M, Wold S. New chemical descriptors for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J. Med. Chem. 1998; 41: 2481-2491.
11. Yin JJ, Diao YB, Wen ZN, Li M. Studying peptides biological activities based on multidimensional descriptors (E) using support vector regression. Int. J. Pept. Res. Ther. 2010; 16: 111-121.
12. Hemmateenejad B, Yousefinejad S, Mehdipour AR. Novel amino acids indices based on quantum topological molecular similarity and their application to QSAR study of peptides. Amino Acids 2011; 40:1169-1183.
13. Wang XY, Wang J, Lin Y, Ding Y. QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors. J. Mol. Model. 2010; 17:1599-1606.
14. Hou TJ, McLaughlin W, Lu BZ, Chen K, Wang W. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis. J. Proteome Research. 2006; 5: 32-43.
15. Hou TJ, Zhang W, Case DA, Wang W. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain. J. Mol. Biol. 2008; 376: 1201-1214.
16. Hou TJ, N Li, Li YY, Wang W. Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. J. ProteomeResearch. 2012; 11: 2982-2995.
17. Xu Z, Hou TJ, Li N, Xu Y, Wang W. Proteome-wide detection of Abl1 SH3 binding peptides by integrating computational prediction and peptide microarray. Mol. Cell. Biochem. 2012; 11: 2982-2995.
18. Hou TJ, Li YY, Wang W. Prediction of peptides binding to the PKA RIIα subunit using a hierarchical strategy. Bioinformatics 2011; 27: 1814-1821.
19. Hou TJ, Xu Z, Wang W, McLaughlin WA, Case DA, Xu Y. Characterization of domain-peptide interaction interface: a generic structure-based model to decipher the binding specificity of SH3 domains. Mol. Cell. Proteomics 2009; 8: 639-649.
20. Hou TJ, Chen K, McLaughlin W, Lu BZ, Wang W. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain. PLoS Comput. Biol. 2006; 2: 46-55.
21. Gu CG, Ju XH, Jiang X, Wang F, Yang SG, Sun C. DFT study on the bromination pattern dependence of electronic properties and their validity in quantitative structure-activity relationships of polybrominated diphenyl ethers. SAR QSAR Environ. Res. 2009; 20: 287-307.
22. Kar S, Harding AP, Roy K, Popelier PLA. QSAR with quantum topological molecular similarity indices: toxicity of aromatic aldehydes to Tetrahymena pyriformis. SAR QSAR Environ. Res. 2010; 21: 149-168.
23. Todescini R, Consonni V, Mauri A, Pavan M. Dragon-web version 5.2, 2004.
24. Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001; 58: 109-130.
25. Wold S, Trygg J, Berglund A, Antti H. Some recent developments in PLS modeling. Chemom. Intell. Lab. Syst. 2001; 58: 131-150.
26. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P, Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
27. Sawa H, Kawaguchi H, Mochizuki N, Endo Y, Kudo T, Tokuchi F, Fijioka Y, Nagashima K, Kitabatake A. Distribution of angiotensinogen in diseased human hearts. Mol. Cell. Biochem. 1994; 132: 15-23.
28. Hassell CH. The design and synthesis of new triazolo-, pyrazolo-, and pyridazo-pyridazine derivatives as inhibitors of angiotensin converting enzyme. J. Chem. Soc. Perkin Trans. I. 1984; 23: 155-162.
29. Zaliani A, Gancia E. MS-WHIM scores for amino acids: A new 3D-description for peptide QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 1999; 39: 525-533.
30. Hellberg S, Eriksson L, Jonsson J, Lindgren F, Sjostrom M, Skagerberg B, Wold S, Andrews P. Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. Int. J. Pept. Protein Res. 1991; 37: 414-424.
31. Collantes ER, Dunn WJ. Amino acid side chain descriptors for quantitative structure activity relationship studies of peptide analogues. J. Med. Chem. 1995; 38: 2705-2713.
32. Mei H, Liao ZH, Zhou Y, Li ZL. A new descriptor of amino acids and its application in peptide QSARs. Biopolymers (Pept. Sci.) 2005; 80: 775-786.
33. Cocchi M, Johansson E. Amino acids characterization by GRID and multivariate data analysis. Quant. Struct-Act Relat. 1993; 12: 1-8.
34. Li SZ, Fu BH, Wang YQ, Liu SS. On structural parameterization and molecular modeling of peptide analogues by molecular electronegativity-edge vector (VMEE): estimation and prediction for biological activity of pentapeptides. J. Chin. Chem. Soc. 2001; 48: 937-944.
35. Liang GZ, Zhou P, Zhou Y, Zhang QX, Li ZL. New descriptors of amino acids and their applications to peptide quantitative structure activity relationship. Acta Chimica Sinica. 2006; 64: 393-396.
36. Zhou P, Zhou Y, Wu SR, Li B, Tian FF, Li ZL. A new descriptor of amino acids based on the three dimensional vector of atomic interaction field. Chinese Sci. Bull. 2006; 51: 524-529.
37. Iwashita T. Asymptotic null and nonnull distribution of Hotelling's T2-statistic under the elliptical distribution. J. Stat. Plan. Infer. 1997; 61: 85-104.
38. George JP, Chen Z, Shaw P. Fault detection of drinking water treatment process using PCA and Hotelling's T2 chart. Comb. Chem. High T. Scr. 2009; 50: 970-975.
39. Polanski J, Gieleciak R, Bak A. Probability issues in molecular design: predictive and modeling ability in 3D-QSAR schemes. Comb. Chem. High Throughput Screen. 2004; 7: 793-807.
40. Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR. Comb. Sci. 2003; 22: 69-77.
41. Polanski J, Bak A, Gieleciak R, Magdziarz T. Modeling robust QSAR. J. Chem. Inf. Model. 2006; 46: 2310-2318.
42. Golbraikh A, Tropsha A. Beware of q2!. J. Mol. Graphics. Mod. 2002; 20: 269-276.
43. Patel S, Stott IP, Bhakko M, Elliott P. Patenting computer-designed peptides. J. Computer-Aided Mol. Design. 1998; 12: 543-556.
44. Mei H, Zhou Y, Sun LL, Li ZL. A new descriptor of amino acid and its application in peptide QSAR. Acta Phys. Chim. Sin. 2004; 20: 821-825.
45. Adenot M, Sarrauste C, Chavanieu A, Calas B, Grassy G. Peptides quantitative structure-function relationships: an automated mutation strategy to design peptides and pseudopeptides from substitution matrices. J. Mol. Graphics Mod. 1999; 17: 292-309.